SACRAMENTO, Calif., Dec. 20, 2016 -- A payload of six lithium-ion batteries, designed and developed by Aerojet Rocketdyne, Inc., a subsidiary of Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD), has been delivered to the International Space Station to give astronauts the power they need to continue important research aboard the station. Once installed on the space station, the batteries will become part of the most sophisticated, high-power space Electrical Power System (EPS) on orbit today. Aerojet Rocketdyne made key contributions to the space station’s EPS design, which includes the batteries, solar arrays and power distribution system.
“Efficient, reliable and safe electrical power systems are absolutely critical for the astronauts who live on the International Space Station. It’s also important for the research they conduct to better understand life in space and here on Earth,” said Aerojet Rocketdyne CEO and President Eileen Drake. “It’s a privilege to know our lithium-ion batteries are helping to make that possible.”
The safety features incorporated into the lithium-ion batteries include voltage, temperature and cell-overcharge monitoring, making them a safe, reliable and efficient power source for the space station. The six lithium-ion batteries will replace 12 of the space station’s nickel hydrogen (Ni-H2) batteries, and will provide a more efficient form of energy storage. They are designed to operate at least 10 years. Eighteen more Aerojet Rocketdyne lithium-ion batteries will be launched to the space station in 2018, 2019 and 2020.
Aerojet Rocketdyne built a total of 31 lithium-ion Orbital Replacement Units that include two engineering units, two qualification units and 27 flight units. Twenty-four of the Aerojet Rocketdyne lithium-ion batteries will replace all 48 existing Ni-H2 batteries, and will be installed on the EPS which supplies power to the space station. The batteries will result in nearly one-half of the launch mass and about 1.5 times more energy storage capability.
Aerojet Rocketdyne is an innovative company delivering solutions that create value for its customers in the aerospace and defense markets. The company is a world-recognized aerospace and defense leader that provides propulsion and energetics to the space, missile defense and strategic systems, tactical systems and armaments areas, in support of domestic and international markets. Additional information about Aerojet Rocketdyne can be obtained by visiting our websites at www.Rocket.com and www.AerojetRocketdyne.com.
Contact: Glenn Mahone, Aerojet Rocketdyne, 202-302-9941 [email protected] Carri Karuhn, Aerojet Rocketdyne, 818-586-4963 [email protected]


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



